TrialBMJ open diabetes research & care2021

Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial.

Masato Yoneda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.